New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareLeuprolide vs Epithalon

Leuprolide vs Epithalon

Side-by-side comparison of key properties, dosing, and research.

Sexual Health & Libido
Leuprolide
Anti-Aging & Longevity
Epithalon
Summary
Leuprolide is a synthetic GnRH superagonist that, with continuous administration, paradoxically suppresses LH and FSH through receptor desensitization — the opposite effect of pulsatile GnRH. Used medically for prostate cancer, endometriosis, and precocious puberty. In men's health, short-duration use for PCT and testosterone suppression rebound.
Epithalon is a synthetic tetrapeptide developed from the pineal gland extract Epithalamin by Russian scientist Dr. Vladimir Khavinson. It is one of the most researched longevity peptides, known for activating telomerase and extending telomere length — the molecular hallmarks of cellular aging.
Half-Life
~3 hours (SC/IM), but depot formulations last 1–12 months
2–4 hours
Admin Route
SubQ, IM
SubQ, Sublingual
Research
Typical Dose
7.5 mg monthly, 22.5 mg 3-monthly, or 45 mg 6-monthly
5–10 mg total per cycle
Frequency
Per depot schedule
0.5–1 mg daily
Key Benefits
  • Medical: reduces testosterone in prostate cancer
  • Medical: suppresses estrogen in endometriosis and uterine fibroids
  • Medical: delays precocious puberty
  • Research: testosterone rebound effect after short course
  • Transgender care: hormone suppression in adolescents
  • Research: hormonal re-sensitization protocols
  • Activates telomerase enzyme, extending telomere length
  • May slow cellular and biological aging
  • Regulates melatonin production and circadian rhythms
  • Improves sleep quality
  • Powerful antioxidant properties
  • May reduce incidence of age-related diseases
  • Supports immune system function
  • Studied for cancer prevention properties in animal models
Side Effects
  • Hot flashes (with testosterone suppression)
  • Decreased libido and erectile dysfunction
  • Initial testosterone flare (first 1–2 weeks)
  • Bone density loss with long-term use
  • +3 more
  • Injection site irritation (mild)
  • Temporary sleep changes during cycle (usually improves)
  • Rare: fatigue
Stacks With